drugset / Trial / NCT00609154
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
Phase 1/2
Terminated
20 enrolled
Albert Einstein College of Medicine
Merck Sharp & Dohme LLC · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupOpen-labelBasic science
Summary
The gut hormone glucagon like peptide-1 (GLP-1) has been shown to have important effects on maintaining the function and health of the insulin producing beta cells. This hormone is known to increase the production rate of new insulin as well as increase the release of insulin into the blood.
Timeline
- Start
- 2010-08-12
- Primary completion
- 2014-05-13
- Completion
- 2014-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLP-1 | Peptide | 1 unknown | — |